Journal Basic Info

  • Impact Factor: 1.989**
  • H-Index: 6
  • ISSN: 2637-4625
  • DOI: 10.25107/2637-4625
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Gastroenterological Surgery
  •  Otolaryngology & ENT Surgery
  •  Cardiac Surgery
  •  Oral & Maxillofacial Surgery
  •  Anesthesiology
  •  Orthopaedic Surgery
  •  Reconstructive Surgery
  •  Hand Surgery

Abstract

Citation: World J Surg Surg Res. 2021;4(1):1282.DOI: 10.25107/2637-4625.1282

The Incidence of Gastroesophageal Reflux Disease after Laparoscopic Sleeve Gastrectomy and Related Risk Factors

Amany Altoies2, Alam Ara Shafi1*, Fahad Almohaizey2, Salman Nawaf Almutairi2, Ashah Lail Aladwany2, AlSuhaibani YA1 and Muhammad Abukhater1

1Department of Surgical Oncology, King Fahad Medical City (KFMC), Riyadh, Saudi Arabia
2King Saud University of Health Sciences, Riyadh, Saudi Arabia

*Correspondance to: Alam Ara Shafi 

 PDF  Full Text Review Article | Open Access

Abstract:

Background: Bariatric Surgery (BS) is considered a terminal and successful treatment modality for
morbidly obese individuals with Laparoscopic Vertical Sleeve Gastrectomy (LVSG) being the most
frequently performed BS throughout the globe. Although, LVSG has gained much popularity for
its simplicity and effectiveness; however, a percentage of patients found to develop a post-operative
spectrum of symptoms called de novo Gastroesophageal Reflux Disease (GERD).
Methodology: A single-center retrospective cohort study from the Middle East was conducted on
obese patients who underwent LVSG between 2013 to 2018 without a prior history of GERD. The
patient population included was adolescent, young, and middle-aged individuals. The data was
collected from the patient’s record after searching the hospital database and it was analyzed by the
statistical package of Social Sciences (SPSS) version 25.
Results: 457 patients underwent LSG by three surgeons over a period of six years with a mean age of
34.6 ± 10.2 years (range 16, 64). Among 48 (10.5%) have had confirmed de novo GERD. Comparison
of disease studied across gender revealed, 34 (72.3%) individuals who had GERD were females while
13 (27.7%) of them were males (p-value 0.118); all cases were Saudis 48 (100.0%). The median time
of onset of GERD after surgery was 43 weeks (range 1 to 219). 25 (52.1%) patients had one symptom,
17 (35.4%) had 2 symptoms, 5 (10.5%) of them had 3 symptoms. GERD was first diagnosed based
upon clinical symptoms and signs in 36 (75.0%), on Gatrografen in 16 patients (33.3%), and Upper
GI endoscopy in 11 (22.9%) patients. De novo GERD was found to correlate with comorbidities and
age (p-value 0.022 and 0.013 respectively).
Conclusion: LVSG is an effective surgical intervention for obesity treatment in terms of weight loss
measures with a much lower incidence of de-novo GERD in the current study. There is insufficient
but statistically significant evidence of a higher incidence of de-novo GERD in the comorbid and
older population as compared to otherwise healthy and younger individuals regardless of their
preoperative BMI.

Keywords:

Bariatric surgery; Laparoscopic sleeve gastrectomy; Gastroesophageal reflux disease; Risk factors

Cite the Article:

Altoies A, Shafi AA, Almhaizey F, Almutairi SN, Aladwany AL, AlSuhaibani YA, et al. The Incidence
of Gastroesophageal Reflux Disease after Laparoscopic Sleeve Gastrectomy and Related Risk Factors. World J Surg Surgical Res. 2021; 4: 1282..

Search Our Journal

Journal Indexed In

Articles with Grants

LAMA1 is a Potential Molecule Associated with Poor Prognosis in Patients with Rectal Adenocarcinoma
 Abstract  PDF  Full Text
Clinical Efficacy of Radiotherapy Combined with Surgery for Locally Advanced Gastric Signet-Ring-Cell Carcinoma
 Abstract  PDF  Full Text
View More...